Prospect Capital Corporation 6.25% Notes due 2028 (PBY) Fundamentals

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food out of which the Therapeutics segment act as a key revenue driver for the firm.
SHARE INFORMATION
Market Cap$ 1,269,682,925
Shares Outstanding50,787,317
Float44,891,336
Percent Float88.39%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 115,529,000
Latest Fiscal EPS$ -1.37
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date2021-05-28
Dividend Rate$ 1.56
Dividend Yield6.25%
Payment Cash-
HOLDERS
Institutions148
Institutional Holdings Date2019-11-30
Institutional Bought Previous 3 Months2,032,563
Institutional Holdings Percent52.9%
Institutional Sold Previous 3 Months1,602,197
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned5,895,981
TRADING INFO
52 Week High$ 26.75
52 Week Low$ 23.06
52 Week High Change$ 12.29
21 Day Moving Average$ 25.0831
21 Day Extended Moving Average$ 25.2394
50 Day Moving Average$ 25.2168
50 Day Extended Moving Average$ 25.4165
200 Day Moving Average$ 24.8262
200 Day Extended Moving Average$ 25.1617
10 Day Average Volume7,622
20 Day Average Volume8,394
30 Day Average Volume6,892
50 Day Average Volume5,043
Alpha-0.004760
Beta0.6285
Standard Deviation0.051185
R20.443202
7 Day Price Change$ -0.07
7 Day Percent Change-0.28%
21 Day Price Change$ -0.20039
21 Day Percent Change-0.8%
30 Day Price Change$ -0.23219
30 Day Percent Change-0.92%
Month to Date Price Change$ -0.10
Month to Date Percent Change-0.4%
Quarter to Date Price Change$ -0.21615
Quarter to Date Percent Change-0.86%
180 Day Price Change$ 0.17432
180 Day Percent Change0.7%
200 Day Price Change$ -0.20327
200 Day Percent Change-0.81%
Year to Date Price Change$ 0.22281
Year to Date Percent Change0.9%

Prospect Capital Corporation 6.25% Notes due 2028 (PBY) Key Ratios

PROFITABILITY
EBIT Margin-246.4%
EBITDA Margin-221.0%
Pre-Tax Profit Margin-393.3%
Profit Margin Count-41.15%
Gross Margin0.0%
Profit Margin TOT-41.15%
INCOME STATEMENTS
Revenue$ 37,512,000
Revenue Per Share$ 0.7386
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.20
Total Debt To Equity0.30
Int Coverage-281.80
Current Ratio4.60
Leverage Ratio2.50
Quick Ratio4.40
Long Term Debt To Capital0.20
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 292,466,452
Price to Sales33.8474
Price to Free Cash-5.40
PE High Last 5 Years0.00
Price To Book3.20
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book3.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.20
Invoice Turnover0.00
Assets Turnover0.20
Return Assets-37.07
Return on Equity-96.70
Return on Capital-76.33

Prospect Capital Corporation 6.25% Notes due 2028 (PBY) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorDeloitte & Touche LLP
CEOMichael Amoroso
Emplyoees192
Last AuditUQ
CIK0001357874
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address302 East Pettigrew Street
Dibrell Building, Suite A-100
Durham, NC 27701
Websitehttps://www.precisionbiosciences.com
Facsimile+1 480 393-5553
Telephone+1 919 314-5512
EmailIR@precisionbiosciences.com
Your Recent History
NYSE
PBY
Prospect C..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220930 20:47:50